Plain-English translation of NCT06133712 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
This study doesn't follow the usual testing phases — it may be an observational study or a different type of research.
Carpal tunnel syndrome happens when a nerve in your wrist gets squeezed, causing pain and numbness in your hand. This trial compares three different injectable treatments — , , and — to see which one works best at relieving pain for the longest time. Each treatment is injected near the affected nerve in the wrist.
Currently, doctors use steroid injections to treat carpal tunnel syndrome, but there's no agreement on which steroid works best or is safest. This study exists to find out whether one of these medications — or therapy — might work better or longer than the standard treatments used today.
You likely qualify if…
You likely don't qualify if…
You would visit the clinic to receive a single injection near the median nerve in your wrist using ultrasound guidance. The injection uses a small needle and takes only a few minutes. You would then be asked to rate your pain before the injection and again after treatment to see how well it works over time. The study team will also perform nerve testing before and after to measure any changes.
AI-generated summary from trial data · Jul 4, 2026 · Not medical advice
Egypt
Tanta University
Enrollment target
~135 participants
Started
November 2023
Primary completion
December 2025
This trial's estimated completion date has passed — the record may not be fully up to date.
Age range
20 Years – 60 Years
Last updated on clinicaltrials.gov in May 2025.
Reach out to the team running this trial. Response times vary — some teams are faster than others.
Central contact
Mahmoud T Elgebaly, MD
Tanta faculty of medicine
Tell us you're interested and we'll help connect you with the research team. We'll walk you through what to expect first — no email needed to get started.